The product has been returned and analysis is in progress.Upon completion of analysis, a supplemental report will be submitted.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Upon receipt at medtronic¿s quality laboratory, visual examination showed the valve was slightly distorted; oval shaped.The non-coronary cusp was in the closed position.The left and right cusps were in the open position.All leaflets were stiff but slightly flexible except where calcification was noted.Tissue deterioration due to visible calcification was observed on all leaflets near the commissures.An intracuspal hematoma was noted on inflow aspect of the non-coronary leaflet.Tissue deterioration due to visible calcification was present on all commissures.A small amount of pannus was noted on the superior coaptive area of all commissures.There was no evidence of commissure dehiscence.Pannus lined the sewing ring on the inflow adjacent to the right and left cusps, extending over the base stitching, to the inflow margin of the attachment, encroaching 1 mm to 8 mm on to the cusps and into the inferior coaptive areas between the right and left cusps.Remnants of a thin layer of pannus was observed on the sewing ring (inflow aspect) extending to the outflow rails and stent posts.An unknown amount of pannus appeared to have been removed on the inflow and outflow during explant.Radiography confirmed calcification at the commissures.Reduced performance of the valve is attributed to host tissue overgrowth.This finding is generally considered a patient-related condition.Serial number and expiration date added.Manufacturing date added.If information is provided in the future, a supplemental report will be issued.
|